Qianwen Yu Selected Research

Qianwen Yu Research Topics

Disease

19	Neoplasms (Cancer) 10/2021 - 09/2015
7	Breast Neoplasms (Breast Cancer) 10/2021 - 10/2016
6	Glioma (Gliomas) 11/2018 - 08/2015
5	Neoplasm Metastasis (Metastasis) 10/2021 - 10/2016
3	Pancreatic Neoplasms (Pancreatic Cancer) 10/2021 - 11/2019
2	Hyperthermia 10/2021 - 10/2020
2	Triple Negative Breast Neoplasms 10/2021 - 09/2021
2	Brain Neoplasms (Brain Tumor) 01/2016 - 08/2015
1	Inflammation (Inflammations) 10/2021
1	Adenocarcinoma 11/2019
1	Melanoma (Melanoma, Malignant) 11/2019
1	Fibrosis (Cirrhosis) 11/2019
1	Hepatocellular Carcinoma (Hepatoma) 01/2019
1	Pre-Eclampsia (Preeclampsia) 07/2018
1	Residual Neoplasm 04/2018
1	Hypotension (Low Blood Pressure) 01/2018
1	Necrosis 01/2017

Drug/Important Bio-Agent (IBA)

17	Liposomes (Liposome)IBA 10/2021 - 08/2015
13	Peptides (Polypeptides)IBA 10/2020 - 08/2015
12	Paclitaxel (Taxol)FDA LinkGeneric 10/2020 - 08/2015
9	Pharmaceutical PreparationsIBA 10/2021 - 09/2015
6	IntegrinsIBA 11/2019 - 09/2015
5	Therapeutic UsesIBA 10/2021 - 01/2017
4	LigandsIBA 10/2020 - 12/2015
4	Cell-Penetrating PeptidesIBA 11/2018 - 01/2016
3	AcidsIBA 10/2021 - 11/2018
3	CollagenIBA 11/2019 - 10/2016
2	Immune Checkpoint InhibitorsIBA 10/2021 - 11/2019
2	AlbuminsIBA 10/2021 - 10/2020
2	LipidsIBA 10/2020 - 01/2019
2	MicellesIBA 10/2020 - 08/2020
2	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 11/2019 - 01/2018
2	Small Interfering RNA (siRNA)IBA 01/2019 - 07/2018
2	Proteins (Proteins, Gene)FDA Link 01/2019 - 01/2017
2	Losartan (Cozaar)FDA LinkGeneric 01/2018 - 10/2016
2	Arginine (L-Arginine)FDA Link 01/2017 - 12/2015
2	Biological ProductsIBA 12/2015 - 09/2015
1	EnzymesIBA 10/2021
1	Macrophage Colony-Stimulating FactorIBA 10/2020
1	Macrophage Colony-Stimulating Factor Receptor (Receptor, Macrophage Colony Stimulating Factor)IBA 10/2020
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2020
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 10/2020
1	2- (2- (2- chloro- 3- ((1,3- dihydro- 3,3- dimethyl- 1- propyl- 2H- indol- 2- ylidene)ethylidene)- 1- cyclohexen- 1- yl)ethenyl)- 3,3- dimethyl- 1- propylindoliumIBA 10/2020
1	PolyethyleneimineIBA 10/2020
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 08/2020
1	STF 62247IBA 08/2020
1	Neoplasm Antigens (Tumor Antigens)IBA 08/2020
1	Doxorubicin (Adriamycin)FDA LinkGeneric 03/2020
1	CarbonIBA 03/2020
1	Hyaluronic Acid (Hyaluronan)IBA 03/2020
1	Immunologic Adjuvants (Immunologic Adjuvant)IBA 11/2019
1	Galactosylceramides (Galactocerebrosides)IBA 11/2019
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 01/2019
1	Docetaxel (Taxotere)FDA Link 01/2019
1	peptide AIBA 01/2019
1	Transferrin Receptors (Transferrin Receptor)IBA 01/2019
1	Folic Acid (Vitamin M)FDA LinkGeneric 11/2018
1	dNP2 peptideIBA 11/2018
1	Long Noncoding RNAIBA 07/2018
1	aspartic acid glycine arginineIBA 07/2018
1	CytokinesIBA 04/2018
1	Tyrosine Kinase InhibitorsIBA 01/2018
1	vandetanib (ZD6474)IBA 01/2018
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2018
1	Neuropilin-1IBA 01/2018
1	Evans Blue (Blue, Evans)FDA Link 01/2018
1	Indocyanine Green (Cardio-Green)FDA LinkGeneric 01/2017
1	Adenosine Triphosphatases (ATPase)IBA 01/2017
1	Protein-Lysine 6-Oxidase (Lysyl Oxidase)IBA 10/2016
1	6-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA 01/2016
1	arginyl-glycyl-aspartic acidIBA 12/2015

Therapy/Procedure

14	Therapeutics 10/2021 - 01/2016
5	Drug Therapy (Chemotherapy) 10/2021 - 08/2015
3	Immunotherapy 10/2021 - 08/2020
2	Lasers (Laser) 10/2020 - 01/2018
1	Radiotherapy 10/2021
1	Photothermal Therapy 09/2021
1	Intravenous Injections 11/2018